Andrew Bednar

Partner, Advisory
New York

Andrew Bednar has been a Partner at Perella Weinberg Partners since its founding in 2006 and was Co-Head of the Firm’s U.S. Advisory Business until 2013. He previously was Head of U.S. Mergers & Acquisitions at Bank of America and a member of the Investment Banking Executive Committee.  Prior to that, he was a Managing Director at Goldman, Sachs & Co.  Mr. Bednar began his career as a corporate lawyer at Cravath, Swaine & Moore.

Mr. Bednar has led consolidation in the Exchange Industry throughout the last decade.  Representative transactions include advising NYSE on its $10.2 billion sale to Intercontinental Exchange; Deutsche Boerse on its $30 billion announced merger with LSE; NYSE on its $25 billion announced merger with Deutsche Boerse; NYSE on its defense of a $10 billion unsolicited joint bid from NASDAQ and Intercontinental Exchange; and Deutsche Boerse on the $1 billion sale of International Securities Exchange to NASDAQ.

Mr. Bednar also has been a leading advisor in sales of retail consumer brands.  Representative transactions include advising Kate Spade & Co. on its $2.4 billion sale to Coach; J Crew on its $3 billion sale to TPG and Leonard Green; Fifth and Pacific on the sale of Lucky Brands to Leonard Green and on the sale of Juicy Couture to Authentic Brands; Collective Brands on the sale of Payless to Golden Gate Capital and on the sale of Sperry, Saucony and Keds to Wolverine Worldwide; Liz Claiborne on the sale of Mexx to Gores Group; Talbots on its SPAC merger and on its sale to Sycamore Partners; Express on its takeover defense; U.S. Tobacco on its $11.7 billion sale to Altria; and Office Depot on its $3 billion merger with OfficeMax.

Additionally, Mr. Bednar has advised clients in a wide range of other industries, including Transportation, Healthcare, and Technology.  Selected transactions include advising Royal Caribbean Cruises on its $2.1 billion acquisition of Silversea Cruises; Norwegian Cruise Line on its $3 billion acquisition of Prestige Cruises; OMI Corporation on its $2.2 billion sale to Teekay & Torm; Scorpio Tankers on its $1.1 billion acquisition of Navig8 Product Tankers; Merck on its $7.2 billion acquisition of Millipore; Cypress Bioscience on its sale to Royalty Pharma, Visiprise Software on its sale to SAP, Frictionless Software on its sale to SAP; and CSC on its acquisition of iSoft.

Mr. Bednar received a Bachelor of Science and a Masters in Business Administration from Cornell University, and also received a Juris Doctor from Columbia University. He previously served as a member of the Board of Trustees of The Juilliard School.

Mr. Bednar has appeared as a guest commentator on CNBC and Bloomberg Television to discuss a variety of M&A topics, including his expertise in shareholder activism.